NCT07544225: Study Investigating the Safety of Anti-CD19 CAR-T Cells Therapy Produced at Gustave Roussy for Adults With Severe and Refractory Systemic Autoimmune Rheumatic Diseases
- State
- Not started
- Phase
- Phase 1
- People
- 6 planned
- Started
- 1 Dec 2026
- Primary completion
- 1 Feb 2029
- Arms
- Treatment
- Results
- None posted
- 22 Apr 2026: Trial registered